Authors: Bellone, M Iezzi, G Imro, MA Protti, MP

Citation: M. Bellone et al., Cancer immunotherapy: synthetic and natural peptides in the balance, IMMUNOL TOD, 20(10), 1999, pp. 457-462

Authors: Manici, S Sturniolo, T Imro, MA Hammer, J Sinigaglia, F Noppen, C Spagnoli, G Mazzi, B Bellone, M Dellabona, P Protti, MP

Citation: S. Manici et al., Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11, J EXP MED, 189(5), 1999, pp. 871-876

Authors: Ferrarini, M Imro, MA Sciorati, C Heltai, S Protti, MP Pellicciari, C Rovere, P Manfredi, AA Rugarli, C

Citation: M. Ferrarini et al., Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes, INT J CANC, 81(4), 1999, pp. 573-579

Authors: Imro, MA Manici, S Russo, V Consogno, G Bellone, M Rugarli, C Traversari, C Protti, MP

Citation: Ma. Imro et al., Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s), CANCER RES, 59(10), 1999, pp. 2287-2291